Andrew Hindman, CBO at Acorda Therapeutics, holds 384.71K shares in Theravance Biopharma (Ticker: TBPH), holds 15.64K shares in Acorda Therapeutics (Ticker: ACORQ).

See the Hottest Stocks Based on Insider Trading >

Andrew Hindman
Acorda Therapeutics (ACORQ)
CBO

Ranked #32,975 out of 98,624 Corporate Insiders

Profitable Transactions

2 out of 2 Profitable Transactions

Average Return

+38.10%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

99.64%

TBPH

0.36%

ACORQ

A breakdown of Andrew Hindman's holdings

See the Top Stocks by Insiders

Insider Roles

Theravance Biopharma
(TBPH)

SVP & CFO

Acorda Therapeutics
(ACORQ)

CBO

Roles that Andrew Hindman holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Acorda Therapeutics
(ACORQ)

Rating:Informative Sell

Date:May 30, 2018 - May 30, 2019

Return:+64.30%

The most profitable trade made by Andrew Hindman

See the Latest Stocks Traded by Insiders

Andrew Hindman's Trading History

ACORQ

Acorda Therapeutics

Mar 12, 2019

CBO

Uninformative Buy

―

$13.29K

TBPH

Theravance Biopharma

Nov 22, 2022

SVP & CFO

Uninformative Sell

715.65K

$3.64M

List of latest transactions for each holding click on a transaction to see Andrew Hindman's performance on stock

See All Insider Trading from Today

Andrew Hindman insider profile FAQ

What is the percentage of profitable transactions made by Andrew Hindman?

The percentage of profitable transactions made by Andrew Hindman is 100%.

What is the average return per transaction made by Andrew Hindman?

The average return per transaction made by Andrew Hindman is 38.10%.

What stocks does Andrew Hindman hold?

Andrew Hindman holds: ACORQ, TBPH stocks.

What was Andrew Hindman’s latest transaction?

Andrew Hindman latest transaction was an Uninformative Sell of $715.65K.

What was Andrew Hindman's most profitable transaction?

Andrew Hindman’s most profitable transaction was an Informative Sell of ACORQ stock on May 30, 2018. The return on the trade was 64.30%.

What is Andrew Hindman's role in Acorda Therapeutics?

Andrew Hindman's role in Acorda Therapeutics is CBO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Andrew Hindman Insider Profile

Andrew Hindman Acorda Therapeutics (ACORQ)CBO